Efficacy of single dose of 800μg of misoprostol in first trimester abortion
DOI:
https://doi.org/10.3126/jonmc.v1i2.7293Keywords:
Misoprostol, abortion, uterine curettageAbstract
Objective: To assess the efficacy, safety and cost effectiveness of Misoprostol (Prostaglandin E1 analogue) as a single dose of 800?g in first trimester abortion
Methods: A descriptive study was conducted in Nobel Medical College and Teaching Hospital from June 2010-June 2011 where 110 patients were enrolled for first trimester abortions including incomplete, missed, blighted ovum. Each woman received a single dose of 800?g of Misoprostol intravaginally and the the process of abortion was monitored to assess the outcome measures.
Results: Successful abortion was seen in 102 patients (92.7%) with induction to delivery interval of < 24 hours and the remaining 8 (7.2%) of them had to undergo surgical evacuation. Side effects noted were lower abdominal pain, fever, nausea, vomiting, and diarrhoea. Mean hospital stay of the patients was 48 hours.
Conclusion: Misoprostol is a safe, cost effective and efficacious drug for first trimester abortion even as a single dosage.
DOI: http://dx.doi.org/10.3126/jonmc.v1i2.7293
Journal of Nobel Medical College (2012), Vol.1 No.2 p.11-13
Downloads
Downloads
Published
How to Cite
Issue
Section
License
JoNMC applies the Creative Commons Attribution (CC BY) license to works we publish. Under this license, authors retain ownership of the copyright for their content, but they allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited.
